| related words |
| fda |
| clearance |
| indication |
| human |
| collaborator |
| testing |
| recall |
| therapy |
| generic |
| marketed |
| ingredient |
| collaboration |
| obtained |
| patient |
| modification |
| responsibility |
| diagnostic |
| study |
| therapeutic |
| withdrawal |
|
| related documents |
| 1005201--3/9/2010--DEPOMED_INC |
| 737207--3/17/2008--NASTECH_PHARMACEUTICAL_CO_INC |
| 1005201--3/12/2008--DEPOMED_INC |
| 912183--2/29/2008--CUBIST_PHARMACEUTICALS_INC |
| 1162192--3/31/2008--AVALON_PHARMACEUTICALS_INC |
| 1012140--3/5/2007--ONYX_PHARMACEUTICALS_INC |
| 874766--2/12/2009--HARTFORD_FINANCIAL_SERVICES_GROUP_INC/DE |
| 1005201--3/6/2009--DEPOMED_INC |
| 1162192--3/31/2009--AVALON_PHARMACEUTICALS_INC |
| 1162192--3/31/2006--AVALON_PHARMACEUTICALS_INC |
| 1361872--3/13/2009--Shermen_WSC_Acquisition_Corp |
| 1162192--3/30/2007--AVALON_PHARMACEUTICALS_INC |
| 1012140--3/16/2006--ONYX_PHARMACEUTICALS_INC |
| 1178711--3/17/2008--NOVACEA_INC |
| 1178711--4/2/2007--NOVACEA_INC |
| 1172480--3/4/2010--SANTARUS_INC |
| 1051514--3/4/2010--ELECTRO_OPTICAL_SCIENCES_INC_/NY |
| 907562--3/12/2010--DYAX_CORP |
| 879993--3/4/2010--DUSA_PHARMACEUTICALS_INC |
| 716646--6/16/2008--CLINICAL_DATA_INC |
|
| related topics |
| {product, liability, claim} |
| {product, candidate, development} |
| {cost, regulation, environmental} |
| {investment, property, distribution} |
| {interest, director, officer} |
| {provision, law, control} |
| {financial, litigation, operation} |
| {cost, contract, operation} |
| {stock, price, operating} |
| {regulation, government, change} |
| {stock, price, share} |
| {tax, income, asset} |
| {control, financial, internal} |
| {product, market, service} |
| {operation, international, foreign} |
| {acquisition, growth, future} |
| {cost, operation, labor} |
| {property, intellectual, protect} |
| {system, service, information} |
| {condition, economic, financial} |
|